Glycogen synthase kinase-3-beta (GSK-3-beta) inhibition as a promising drug target for the treatment of comorbid Alzheimer's disease or schizophrenia, and depression
2013
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI